Search

everythinglearnresearchcommunity

for

Search:↓

About 13% of women had idiopathic hirsutism and 8.5% had polycystic ovary syndrome in a group of Iranian women.

Non-binary transgender individuals need personalized hormonal treatments for better well-being and quality of life.

Spironolactone improved blood vessel function and cholesterol levels in non-obese women with PCOS.

South Asian women with PCOS experience more psychological distress and have a poorer quality of life, especially in social relationships, with hirsutism affecting them more than obesity.

Finasteride effectively treats hirsutism in women, but more research needed for long-term results.

Women with regular menstrual cycles and PCOS have linked kisspeptin and LH hormone patterns, unlike those with irregular cycles.

The document concludes with guidance for doctors on diagnosing and treating hirsutism effectively and safely.

Different treatments for alopecia areata have varying success rates and side effects; intralesional steroids are most effective.

Spironolactone helps reduce pain and lesions in hidradenitis suppurativa patients, and lower doses are also effective.

Women with PCOS often have hair loss, which is linked to acne or excess body hair but not to worse hormone or metabolic issues.

Polycystic Ovary Syndrome is common but often undiagnosed, and early treatment is important to prevent health problems.

Anorexia nervosa can cause skin problems, which may help with early diagnosis and usually improve with treatment.

LGBT individuals have unique skin health needs, including higher STD risks and side effects from gender-affirming treatments, requiring dermatologists to offer knowledgeable and culturally competent care.

The skin's ability to produce hormones is linked to various skin conditions, and better understanding this process could lead to new treatments.

Spironolactone plus finasteride reduces hirsutism more effectively.

Hormonal treatments are effective for severe or persistent acne and should be used with other acne therapies, considering potential side effects.

Hormone imbalances can cause specific skin changes, which may help in early detection of endocrine disorders.

Testosterone therapy is generally safe for transmen, improves sexual function, and has manageable health risks with proper monitoring.

A comprehensive approach to educating patients and managing side effects is crucial for improving adherence to multiple sclerosis treatments and patient quality of life.

Melatonin improved mental health and metabolism in women with PCOS.

Women with PCOS have similar levels of certain proteins compared to women without PCOS, and these proteins don't independently cause PCOS.

Women with PCOS have lower ghrelin levels and a weaker response to sugar, which might affect their feeling of fullness and lead to overeating.

Accurate diagnosis is key for treating different kinds of hair loss, and immune response variations may affect the condition and treatment results.

Combination drug therapy is effective for hirsutism that doesn't improve with just one medication.

FAGA diagnosis uses blood tests and trichoscopy, with treatments like topical minoxidil, oral anti-androgens, and hormone-modulating drugs.

Certain metabolites are lower in women with PCOS and could be potential markers for the condition.

Women with PCOS are more likely to have insulin resistance and obesity, especially those with the most severe type I PCOS.

The conclusion is that oral contraceptives and antiandrogens can treat hirsutism and acne in women with cutaneous hyperandrogenism, but more research is needed for effective treatments, especially for hair loss.

Women with PCOS often have mood disorders and a lower quality of life, and treatment should focus on both physical and mental health.

The research found that polycystic ovary syndrome (PCOS) has two distinct types, with one having more severe hormone and insulin issues.